Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

PURPOSE: To determine if incorporation of an additional cytotoxic agent improves overall survival (OS) and progression-free survival (PFS) for women with advanced-stage epithelial ovarian carcinoma (EOC) and primary peritoneal carcinoma who receive carboplatin and paclitaxel. PATIENTS AND METHODS: W...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bookman, Michael A., Brady, Mark F., McGuire, William P., Harper, Peter G., Alberts, David S., Friedlander, Michael, Colombo, Nicoletta, Fowler, Jeffrey M., Argenta, Peter A., De Geest, Koen, Mutch, David G., Burger, Robert A., Swart, Ann Marie, Trimble, Edward L., Accario-Winslow, Chrisann, Roth, Lawrence M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2009
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2668552/
https://ncbi.nlm.nih.gov/pubmed/19224846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.1684
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak